BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3035030)

  • 1. Biologic properties of LTB4 and paf-acether in vivo in human skin.
    Michel L; Mencia-Huerta JM; Benveniste J; Dubertret L
    J Invest Dermatol; 1987 Jun; 88(6):675-81. PubMed ID: 3035030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
    Hopkins NK; Schaub RG; Gorman RR
    Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil aggregating properties of PAF-acether and leukotriene B4.
    Ford-Hutchinson AW
    Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for studying chemotaxis, vascular permeability and histological modifications induced by mediators of inflammation in vivo in man.
    Michel L; Dubertret L
    Br J Dermatol; 1985 Jul; 113 Suppl 28():61-6. PubMed ID: 2990519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene B4 and platelet-activating factor in human skin.
    Michel L; Dubertret L
    Arch Dermatol Res; 1992; 284 Suppl 1():S12-7. PubMed ID: 1337424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis.
    Thomsen MK; Larsen CG; Thomsen HK; Kirstein D; Skak-Nielsen T; Ahnfelt-Rønne I; Thestrup-Pedersen K
    J Invest Dermatol; 1991 Feb; 96(2):260-6. PubMed ID: 1846901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte chemotaxis in the canine trachea: inhibition by lipid mediator antagonists and systemic inhibitors.
    Johnson HG; McNee ML
    Agents Actions; 1991 Jul; 33(3-4):260-71. PubMed ID: 1659154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.
    Touvay C; Vilain B; Etienne A; Sirois P; Borgeat P; Braquet P
    Immunopharmacology; 1986 Oct; 12(2):97-104. PubMed ID: 3021651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4.
    Hopkins NK; Lin AH; Gorman RR
    Biochim Biophys Acta; 1983 Oct; 763(3):276-83. PubMed ID: 6313071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative differences and combined effects of interleukin-8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn.
    Tan ND; Davidson D
    Pediatr Res; 1995 Jul; 38(1):11-6. PubMed ID: 7478787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
    Iwamoto I; Tomoe S; Tomioka H; Yoshida S
    J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of PAF-acether to induce in vivo neutrophil migration.
    Cunha FQ; Heluy-Neto NE; Klein A; Souza GE; Ferreira SH
    Agents Actions; 1988 Aug; 25(1-2):191-4. PubMed ID: 3055873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
    Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4.
    Casillan AJ; Gonzalez NC; Johnson JS; Steiner DR; Wood JG
    J Appl Physiol (1985); 2003 Jun; 94(6):2313-22. PubMed ID: 12598480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte-induced vascular protein leakage in cat mesentery.
    Kubes P; Grisham MB; Barrowman JA; Gaginella T; Granger DN
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1872-9. PubMed ID: 1684268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis.
    Gaudreault E; Stankova J; Rola-Pleszczynski M
    Prostaglandins Other Lipid Mediat; 2005 Jan; 75(1-4):25-34. PubMed ID: 15789613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.